Upgrade to SI Premium - Free Trial

Endologix (ELGX)

0.22 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- M&A (1/31/16 *Est)

Latest Headlines

PECA Labs Receives Expanded CE Mark for exGraft Family of Vascular Grafts, Allowing for Expandability Designed to Match Growth or Help Avoid Restenosis March 19, 2024 7:05 AM - BizWire Full Article List